ProfileGDS5678 / 1447152_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 47% 47% 48% 47% 46% 50% 48% 48% 48% 57% 47% 51% 48% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1375547
GSM967853U87-EV human glioblastoma xenograft - Control 23.1131247
GSM967854U87-EV human glioblastoma xenograft - Control 33.1161747
GSM967855U87-EV human glioblastoma xenograft - Control 43.0677248
GSM967856U87-EV human glioblastoma xenograft - Control 53.0613547
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1856446
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.2687850
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1226148
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1055748
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.10748
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4513857
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.070447
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2548251
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1213448